Biotech Values

[dewophile]

i hope the company clarifies when the 5 criteria were in fact put forth long before we wait on the FDA's response. they are presenting as far as i know at JPM again so there's an opportunity. obviously if amphastar met the 5 criteria then i agree with peter assessment that teva's claims gain credibility (although immunogenicity hurdle still looms). it would have been nice to have the letter as an exhibit. it's omission, like your point about immuno being part of the criteria that by their own admission they have not yet met, all lends credence to the notion that they did not meet the 5 criteria back in 2007, but it would be nice to get confirmation